Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study.

Vulciu PA, Pilat L, Varga NI, Dascau V, Popa C, Mot MD, Barata PI, Donath Miklos I, Puschita M

Open source

DOI
10.2478/rjim-2025-0014
Published
2025 Sep 1
Container
Romanian journal of internal medicine = Revue roumaine de medecine interne
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2478/rjim-2025-0014,
  title = {Tetranectin as a potential biomarker in heart failure with ejection fraction >45\%: A prospective cohort study.},
  author = {Vulciu PA and Pilat L and Varga NI and Dascau V and Popa C and Mot MD and Barata PI and Donath Miklos I and Puschita M},
  year = {2025},
  journal = {Romanian journal of internal medicine = Revue roumaine de medecine interne},
  doi = {10.2478/rjim-2025-0014},
  url = {https://doi.org/10.2478/rjim-2025-0014}
}

RIS

TY  - JOUR
TI  - Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study.
AU  - Vulciu PA
AU  - Pilat L
AU  - Varga NI
AU  - Dascau V
AU  - Popa C
AU  - Mot MD
AU  - Barata PI
AU  - Donath Miklos I
AU  - Puschita M
PY  - 2025
JO  - Romanian journal of internal medicine = Revue roumaine de medecine interne
DO  - 10.2478/rjim-2025-0014
UR  - https://doi.org/10.2478/rjim-2025-0014
ER  - 

APA

PA, V., L, P., NI, V., V, D., C, P., MD, M., PI, B., I, D. M., & M, P. (2025). Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study.. Romanian journal of internal medicine = Revue roumaine de medecine interne. https://doi.org/10.2478/rjim-2025-0014

Source records